BR9807397A - Derivados 4-aminoetoxiindazol - Google Patents
Derivados 4-aminoetoxiindazolInfo
- Publication number
- BR9807397A BR9807397A BR9807397-4A BR9807397A BR9807397A BR 9807397 A BR9807397 A BR 9807397A BR 9807397 A BR9807397 A BR 9807397A BR 9807397 A BR9807397 A BR 9807397A
- Authority
- BR
- Brazil
- Prior art keywords
- derivatives
- alkoxy
- halogen
- phenyl
- alkyl
- Prior art date
Links
- UWFNMXYMTWTJAO-UHFFFAOYSA-N 2-(1h-indazol-4-yloxy)ethanamine Chemical class NCCOC1=CC=CC2=C1C=NN2 UWFNMXYMTWTJAO-UHFFFAOYSA-N 0.000 title 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229940052760 dopamine agonists Drugs 0.000 abstract 2
- 239000003136 dopamine receptor stimulating agent Substances 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 208000007848 Alcoholism Diseases 0.000 abstract 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical group O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 208000000323 Tourette Syndrome Diseases 0.000 abstract 1
- 208000016620 Tourette disease Diseases 0.000 abstract 1
- 201000007930 alcohol dependence Diseases 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 206010013663 drug dependence Diseases 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 208000011117 substance-related disease Diseases 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80132597A | 1997-02-18 | 1997-02-18 | |
| PCT/US1998/002413 WO1998035943A1 (en) | 1997-02-18 | 1998-02-13 | 4-aminoethoxyindazole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9807397A true BR9807397A (pt) | 2000-03-14 |
Family
ID=25180801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9807397-4A BR9807397A (pt) | 1997-02-18 | 1998-02-13 | Derivados 4-aminoetoxiindazol |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0960101A1 (es) |
| JP (1) | JP2001512458A (es) |
| KR (1) | KR20000071125A (es) |
| CN (1) | CN1248246A (es) |
| AR (1) | AR011137A1 (es) |
| AU (2) | AU6246198A (es) |
| BR (1) | BR9807397A (es) |
| CA (1) | CA2278746A1 (es) |
| IL (1) | IL131159A0 (es) |
| WO (2) | WO1998035942A1 (es) |
| ZA (1) | ZA981307B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0511533A (pt) * | 2004-05-26 | 2008-01-02 | Pfizer | derivados indazol e indolona e seu uso como medicamento |
| JP6701214B2 (ja) | 2014-11-03 | 2020-05-27 | イオメット ファーマ リミテッド | 医薬化合物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9305623D0 (en) * | 1993-03-18 | 1993-05-05 | Merck Sharp & Dohme | Therapeutic agents |
| GB9305641D0 (en) * | 1993-03-18 | 1993-05-05 | Merck Sharp & Dohme | Therapeutic agents |
-
1998
- 1998-01-13 AU AU62461/98A patent/AU6246198A/en not_active Abandoned
- 1998-01-13 WO PCT/US1998/001167 patent/WO1998035942A1/en not_active Ceased
- 1998-02-11 AR ARP980100619A patent/AR011137A1/es unknown
- 1998-02-13 WO PCT/US1998/002413 patent/WO1998035943A1/en not_active Ceased
- 1998-02-13 CN CN98802635A patent/CN1248246A/zh active Pending
- 1998-02-13 KR KR1019997007413A patent/KR20000071125A/ko not_active Withdrawn
- 1998-02-13 CA CA002278746A patent/CA2278746A1/en not_active Abandoned
- 1998-02-13 BR BR9807397-4A patent/BR9807397A/pt not_active Application Discontinuation
- 1998-02-13 AU AU62733/98A patent/AU6273398A/en not_active Abandoned
- 1998-02-13 JP JP53584198A patent/JP2001512458A/ja active Pending
- 1998-02-13 IL IL13115998A patent/IL131159A0/xx unknown
- 1998-02-13 EP EP98905000A patent/EP0960101A1/en not_active Withdrawn
- 1998-02-17 ZA ZA9801307A patent/ZA981307B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998035942A1 (en) | 1998-08-20 |
| AU6273398A (en) | 1998-09-08 |
| AR011137A1 (es) | 2000-08-02 |
| WO1998035943A1 (en) | 1998-08-20 |
| AU6246198A (en) | 1998-09-08 |
| IL131159A0 (en) | 2001-01-28 |
| CA2278746A1 (en) | 1998-08-20 |
| KR20000071125A (ko) | 2000-11-25 |
| CN1248246A (zh) | 2000-03-22 |
| ZA981307B (en) | 1999-08-17 |
| JP2001512458A (ja) | 2001-08-21 |
| EP0960101A1 (en) | 1999-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0417771A (pt) | heterociclos azabicìclicos como moduladores de receptor canabinóides | |
| EP1243582A4 (en) | CHINOLINE AND CHINAZOLINE DERIVATIVES AND MEDICATIONS CONTAINING THEM | |
| DE69926806D1 (de) | N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren | |
| DK0923548T3 (da) | 4-Aminoethoxyindoler som dopamin-D2-agonister og som 5HT 1A-ligander | |
| BR0308145A (pt) | Composto, composição farmacêutica, uso de um composto, e, processo para a preparação de um composto | |
| BR0309664A (pt) | Derivados de [1,4]diazepino[6,7,1-ij]quinolina como agentes anti-psicóticos e antiobesidade | |
| BR9916781A (pt) | 4-oxo-1,4-dihidro-3-quinolinacarboxamidas comoagentes antivirais | |
| DE69926919D1 (de) | N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren | |
| BR0016635A (pt) | Moduladores de neurotransmissão de dopamina | |
| BRPI0513672A (pt) | processo aperfeiçoado para a preparação de 2h-1-benzopiran-2metanol, (alfa). (alfa)' [iminobis (metileno)] bis [6-fluoro-3, 4-dihidro, [2r* [r* [r* (s*)]]]], composição farmacêutica, forma t1 amorfa, e processo para a preparação da forma t1 de hidrocloreto de nebivolol | |
| ATE266013T1 (de) | 1-phenyl-4-benzylpiperazine: spezifische liganden für den dopamin rezeptor (d4) | |
| DE60236719D1 (de) | Purinderivate als antagonisten an purinergen rezeptoren | |
| ATE260275T1 (de) | Substituierte thien-3-yl- sulfonylamino(thio)carbonyl-triazolin(thi)one | |
| SE0104341D0 (sv) | New use | |
| BR0112582A (pt) | Sulfonamidas de ciclilamina como agonistas de receptores beta-3 adrenérgicos | |
| PT1204658E (pt) | Agonistas benzofurilpiperazina de serotonina | |
| BR9807397A (pt) | Derivados 4-aminoetoxiindazol | |
| BR0004548A (pt) | Derivados i de quinolin-4-ila | |
| BR9805437A (pt) | Derivados de benzocicloalquenos heterocìclicos, processo para fabricação de derivados de benzocicloalquenos heterocìclicos e uso de derivados de benzocicloalquenos heterocìclicos. | |
| DK1174131T3 (da) | Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom | |
| HUP0104701A2 (hu) | 3-Tetrahidro-piridin-4-il-indolok pszichotikus betegségek kezelésére és a vegyületeket tartalmazó gyógyszerkészítmények | |
| PT1082116E (pt) | Utilizacao de derivados de 4-piperidinometanol no tratamento de desordens do neurodesenvolvimento | |
| ATE227284T1 (de) | 4-aminoethoxy-indolonderivate als dopamin d2 agonisten | |
| CY1113801T1 (el) | Παραγωγο κιναζολινης και φαρμακευτικο ειδος | |
| ES2186639T3 (es) | Nuevos derivados de ((2-sustituido-5-(3-tienil))-bencil)-(2-((2-isopropoxi-5-fluoro)-fenoxi)-etil)-amina, su procedimiento de preparacion y su utilizacion como medicamentos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |